Stock News - GYRE THERAPEUTICS, INC. $GYRE

Latest Stock News for $GYRE
Gyre Therapeutics Submits NDA for F351 to Treat Chronic Hepatitis B-Induced Liver Fibrosis

Expected Stock impact: Noticeably Positive
2026-03-23 11:52:00